share_log

Chimerix | 8-K: Current report

Chimerix | 8-K: Current report

Chimerix | 8-K:重大事件
美股SEC公告 ·  2024/11/14 15:26

Moomoo AI 已提取核心信息

Chimerix submitted a Form 8-K report to the SEC on November 14, 2024, addressing changes in directors or certain officers under Item 5.02 and financial statements and exhibits under Item 9.01. The report was signed by Michelle LaSpaluto in her capacity as Chief Financial Officer.The filing includes an Interactive Data File embedded within the Inline XBRL document as Exhibit 10.1. The company maintains its listing on the Nasdaq Global Market under the symbol CMRX with common stock at par value of $0.001 per share.
Chimerix submitted a Form 8-K report to the SEC on November 14, 2024, addressing changes in directors or certain officers under Item 5.02 and financial statements and exhibits under Item 9.01. The report was signed by Michelle LaSpaluto in her capacity as Chief Financial Officer.The filing includes an Interactive Data File embedded within the Inline XBRL document as Exhibit 10.1. The company maintains its listing on the Nasdaq Global Market under the symbol CMRX with common stock at par value of $0.001 per share.
Chimerix于2024年11月14日向证券交易委员会提交了一份8-k表格报告,报告中涉及第5.02项关于董事或特定高管的变更,以及第9.01项的基本报表和附录。该报告由Michelle LaSpaluto以首席财务官的身份签署。 该文件包括嵌入在Inline XBRL文档中的互动数据文件,作为附件10.1。该公司在纳斯达克全球市场以标的CMRX保持上市,普通股的面值为每股0.001美元。
Chimerix于2024年11月14日向证券交易委员会提交了一份8-k表格报告,报告中涉及第5.02项关于董事或特定高管的变更,以及第9.01项的基本报表和附录。该报告由Michelle LaSpaluto以首席财务官的身份签署。 该文件包括嵌入在Inline XBRL文档中的互动数据文件,作为附件10.1。该公司在纳斯达克全球市场以标的CMRX保持上市,普通股的面值为每股0.001美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息